Send us a text

Prepare for an enlightening exploration of the fascinating terrain of liver diseases. Ever wonder why the medical terminology for liver diseases is changing? We're set to dissect this subject with clarity, navigating through the recent reclassification of terms such as nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - words that have been seen as confusing, stigmatizing, and potentially misleading. Get ready to comprehend the new terms like metabolic dysfunction associated steatotic liver disease, and discover why these changes are more than just nominal.

This captivating episode takes you through the labyrinth of scientific insights behind these diseases, underlining the pivotal role metabolism plays. See how the term MET ALD bridges the divide between metabolic and alcohol-induced liver diseases, recognizing the dual influence of both elements. We have an incredible international panel lined up for you, composed of clinical researchers, educators, industry experts, and patient advocates who have played a crucial role in planning and adopting these new terms. Become part of this intriguing journey as we understand how the nomenclature of liver diseases has evolved!

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!